Regulation of translation initiation by FRAP/mTOR.

Regulation of protein synthesis in eukaryotes plays a critical role in development, differentiation, cell cycle progression, cell growth, and apoptosis (Mathews et al. 2000). Translational control allows for a more rapid response than transcriptional modulation because no mRNA synthesis, processing, or transport is required, and can be used to coordinate gene expression in systems that lack transcriptional regulation, such as reticulocytes or platelets (Weyrich et al. 1998; Mathews et al. 2000). Translational control plays a particularly important role in early developmental processes, when localized translation is utilized to establish polarity (Wickens et al. 2000), and localized translation in neurons may be critical for learning and memory (e.g., Casadio et al. 1999). Following transcription, processing, and nucleocytoplasmic export, mRNAs are competent for translation. However, two transcripts present in identical quantities may be translated at very different rates. This phenomenon is caused, in part, by the fact that the ribosome does not bind to mRNA directly, but must be recruited to mRNA by the concerted action of a large number of eukaryotic translation initiation factors (eIFs). This recruitment step, also referred to as the initiation phase, is a complex process that culminates in the positioning of a charged ribosome (that is, an 80S ribosome loaded with an initiator tRNA in its P site) at an initiation codon (for review, see Hershey and Merrick 2000). As discussed further below, the recruitment process is rate-limiting for translation in many cases, and is subject to exquisite regulation. The structure mGpppN (or the cap, where m is a methyl group and N any nucleotide) is present at the 5 end of all nuclear transcribed mRNAs, and plays an important role in the initiation process. The cap is recognized by the initiation factor eIF4E. eIF4E, via an interaction with a large scaffolding protein termed eIF4G, directs the translational machinery to the 5 end of the mRNA. eIF4E and eIF4G function as components of a trimeric complex, termed eIF4F, which also contains the RNA helicase eIF4A (Gingras et al. 1999b; Hershey and Merrick 2000; Fig. 1). eIF4G also establishes intermolecular contacts with several other components of the translational machinery, including the multisubunit, ribosome-associated initiation factor eIF3 (Hentze 1997; Hershey and Merrick 2000). Importantly, optimal binding of the 40S ribosomal subunit is thought to require a region of single-stranded mRNA (Sonenberg 1993; Gingras et al. 1999b; Hershey and Merrick 2000). Thus, once eIF4F binds to the cap, eIF4A (in conjunction with an associated ubiquitous cofactor, eIF4B) is thought to unwind any inhibitory secondary structure present in the cap-proximal 5 untranslated region (5 UTR). Through its interaction with eIF3 and its ability to bind mRNA in a sequence nonspecific fashion, eIF4G bridges the mRNA to the 40S ribosomal subunit. Once the 40S subunit is bound to mRNA, the ribosome and associated factors are believed to scan in a 5 to 3 direction, until an initiation codon in the proper sequence context is encountered (Kozak 1989; Jackson 2000). When an initiation codon is recognized, and a codon/anticodon interaction established, the initiation factors dissociate from the small ribosomal subunit and allow for the joining of a 60S ribosomal subunit. In this way, a single ribosome is directed to a start codon, and protein synthesis can commence. Treatment of cells with mitogens, hormones, or growth factors generally leads to an increase in translation. Conversely, nutrient deprivation or environmental stresses such as heat shock, osmotic shock, or UV irradiation generally reduce protein synthetic rates (for review, see Kleijn et al. 1998; Gingras et al. 1999b; Mathews et al. 2000; Schneider 2000). In mammalian cells, these changes in translation rates are often correlated with changes in the level or activity of eIF4F, resulting in differences in the rate of ribosomal recruitment to mRNA. That is, growing or stimulated cells contain high levels of eIF4F, whereas in quiescent or stressed cells low eIF4F levels are detected. Mammalian eIF4F formation is regulated by a family of translation repressors, the eIF4E binding proteins (4E-BPs; Lin et al. 1994; Pause et al. 1994). The 4E-BPs constitute a family of three small polypeptides that compete with eIF4G for These authors contributed equally to this work. Corresponding author. E-MAIL nsonen@med.mcgill.ca; FAX (514) 398-1287. Article and publication are at www.genesdev.org/cgi/doi/10.1101/ gad.887201.

[1]  N. Sonenberg,et al.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure. , 2001, RNA.

[2]  P. Vogt,et al.  A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Sonenberg,et al.  A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. , 2001, Molecular cell.

[4]  R. Burcelin,et al.  Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.

[5]  J. Chen,et al.  Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Stuart L. Schreiber,et al.  Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins , 2000, Current Biology.

[7]  M. Kastan,et al.  Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1 , 2000, Nature Cell Biology.

[8]  A. Schmidt,et al.  HEAT Repeats Mediate Plasma Membrane Localization of Tor2p in Yeast* , 2000, The Journal of Biological Chemistry.

[9]  T. P. Neufeld,et al.  Regulation of cellular growth by the Drosophila target of rapamycin dTOR. , 2000, Genes & development.

[10]  E. Hafen,et al.  Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. , 2000, Genes & development.

[11]  R. Abraham,et al.  Mammalian Target of Rapamycin-dependent Phosphorylation of PHAS-I in Four (S/T)P Sites Detected by Phospho-specific Antibodies* , 2000, The Journal of Biological Chemistry.

[12]  Tobias Schmelzle,et al.  TOR, a Central Controller of Cell Growth , 2000, Cell.

[13]  A. Gingras,et al.  Translational Control of the Antiapoptotic Function of Ras* , 2000, The Journal of Biological Chemistry.

[14]  H. Beug,et al.  Isolation of translationally controlled mRNAs by differential screening , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Barry D Kahan,et al.  Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study , 2000, The Lancet.

[16]  Christine C. Hudson,et al.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. , 2000, Cancer research.

[17]  P. Kang,et al.  The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.

[18]  M. McMahon,et al.  Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  R. Fåhraeus,et al.  Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E , 2000, Current Biology.

[20]  A. Bernal,et al.  Drosophila Thor participates in host immune defense and connects a translational regulator with innate immunity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. P. Neufeld,et al.  Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways. , 2000, Developmental biology.

[22]  T. Haystead,et al.  Sites That Govern Translational Repression Phosphorylation of Phas-i in Five (s/t)p Multiple Mechanisms Control , 2022 .

[23]  E. Sonnhammer,et al.  FAT: a novel domain in PIK-related kinases. , 2000, Trends in biochemical sciences.

[24]  J. Flores,et al.  Increased phosphoinositide 3‐kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  A. Gingras,et al.  Regulation of the Rapamycin and FKBP-Target 1/Mammalian Target of Rapamycin and Cap-dependent Initiation of Translation by the c-Abl Protein-tyrosine Kinase* , 2000, The Journal of Biological Chemistry.

[26]  P. Nowell,et al.  The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Schreiber,et al.  FKBP12-Rapamycin-associated Protein (FRAP) Autophosphorylates at Serine 2481 under Translationally Repressive Conditions* , 2000, The Journal of Biological Chemistry.

[28]  G. Mills,et al.  In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  D. Sabatini,et al.  Functional interaction between RAFT1/FRAP/mTOR and protein kinase Cδ in the regulation of cap‐dependent initiation of translation , 2000, The EMBO journal.

[30]  R. Lin,et al.  α1A Adrenergic Receptor Induces Eukaryotic Initiation Factor 4E-binding Protein 1 Phosphorylation via a Ca2+-dependent Pathway Independent of Phosphatidylinositol 3-kinase/Akt* , 2000, The Journal of Biological Chemistry.

[31]  Pier Paolo Pandolfi,et al.  The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.

[32]  S. Gygi,et al.  Serum‐stimulated, rapamycin‐sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI , 2000, The EMBO journal.

[33]  N. Sonenberg,et al.  Eukaryotic Translation Initiation Factor 4E (eIF4E) Binding Site and the Middle One-Third of eIF4GI Constitute the Core Domain for Cap-Dependent Translation, and the C-Terminal One-Third Functions as a Modulatory Region , 2000, Molecular and Cellular Biology.

[34]  J. Hershey,et al.  2 The Pathway and Mechanism of Initiation of Protein Synthesis , 2000 .

[35]  A. Gingras,et al.  6 Regulation of Ribosomal Recruitment in Eukaryotes , 2000 .

[36]  R. Schneider 17 Translational Control during Heat Shock , 2000 .

[37]  R. Jackson 4 A Comparative View of Initiation Site Selection Mechanisms , 2000 .

[38]  七星 雅一 Alpha4 protein as a common regulator of type2A-related serine/threonine protein phosphatases , 2000 .

[39]  O. Meyuhas,et al.  22 Translational Control of TOP mRNAs , 2000 .

[40]  Kenneth M. Kuhn,et al.  19 Cellular Internal Ribosome Entry Site Elements and the Use of cDNA Microarrays in Their Investigation , 2000 .

[41]  S. Kimball,et al.  16 Regulation of Translation Initiation in Mammalian Cells by Amino Acids , 2000 .

[42]  J. Hershey,et al.  20 Translational Control and Cancer , 2000 .

[43]  C. Proud 24 Control of the Elongation Phase of Protein Synthesis , 2000 .

[44]  S. Schreiber,et al.  Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Heitman,et al.  The TOR signaling cascade regulates gene expression in response to nutrients. , 1999, Genes & development.

[46]  D. Goberdhan,et al.  Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. , 1999, Genes & development.

[47]  Michael N. Hall,et al.  The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors , 1999, Nature.

[48]  Bradley FDA approves new immunosuppressants. , 1999, Pharmaceutical science & technology today.

[49]  E. Wilder,et al.  Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB , 1999, Nature Cell Biology.

[50]  C. Proud,et al.  Nutrients differentially regulate multiple translation factors and their control by insulin. , 1999, The Biochemical journal.

[51]  D. Alessi,et al.  Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. , 1999, The Biochemical journal.

[52]  E. Hafen,et al.  PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. , 1999, Development.

[53]  N. Sonenberg,et al.  Opposite Translational Control of GLUT1 and GLUT4 Glucose Transporter mRNAs in Response to Insulin , 1999, The Journal of Biological Chemistry.

[54]  P. Brown,et al.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Kandel,et al.  A Transient, Neuron-Wide Form of CREB-Mediated Long-Term Facilitation Can Be Stabilized at Specific Synapses by Local Protein Synthesis , 1999, Cell.

[56]  E. Hafen,et al.  Drosophila S6 kinase: a regulator of cell size. , 1999, Science.

[57]  T. P. Neufeld,et al.  Regulation of imaginal disc cell size, cell number and organ size by Drosophila class IA phosphoinositide 3-kinase and its adaptor , 1999, Current Biology.

[58]  M. Schummer,et al.  Messenger RNA translation state: the second dimension of high-throughput expression screening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Denton,et al.  Dissociation of the eukaryotic initiation factor‐4E/4E‐BP1 complex involves phosphorylation of 4E‐BP1 by an mTOR‐associated kinase , 1999, FEBS letters.

[60]  J. Heitman,et al.  Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. , 1999, Molecular biology of the cell.

[61]  W. Liu,et al.  Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines* , 1999, The Journal of Biological Chemistry.

[62]  A. Gingras,et al.  Requirement for Akt (Protein Kinase B) in Insulin-induced Activation of Glycogen Synthase and Phosphorylation of 4E-BP1 (PHAS-1)* , 1999, The Journal of Biological Chemistry.

[63]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[64]  D. Barford,et al.  Topological characteristics of helical repeat proteins. , 1999, Current opinion in structural biology.

[65]  Brian A. Hemmings,et al.  Protein Kinase B Localization and Activation Differentially Affect S6 Kinase 1 Activity and Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 Phosphorylation , 1999, Molecular and Cellular Biology.

[66]  A. Gingras,et al.  Translational Homeostasis: Eukaryotic Translation Initiation Factor 4E Control of 4E-Binding Protein 1 and p70 S6 Kinase Activities , 1999, Molecular and Cellular Biology.

[67]  A. Gingras,et al.  Cap-dependent translation initiation in eukaryotes is regulated by a molecular mimic of eIF4G. , 1999, Molecular cell.

[68]  Alfred Wittinghofer,et al.  Structural View of the Ran–Importin β Interaction at 2.3 Å Resolution , 1999, Cell.

[69]  C. Müller,et al.  Structure of importin-β bound to the IBB domain of importin-α , 1999, Nature.

[70]  J. Broach,et al.  Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast , 1999, The EMBO journal.

[71]  H. Trachsel,et al.  CLN3 expression is sufficient to restore G1-to-S-phase progression in Saccharomyces cerevisiae mutants defective in translation initiation factor eIF4E. , 1999, The Biochemical journal.

[72]  S. Snyder,et al.  Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. , 1999, Science.

[73]  L. Shantz,et al.  Leucine Regulates Translation of Specific mRNAs in L6 Myoblasts through mTOR-mediated Changes in Availability of eIF4E and Phosphorylation of Ribosomal Protein S6* , 1999, The Journal of Biological Chemistry.

[74]  I. London,et al.  Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis , 1999, Oncogene.

[75]  Kathryn E. Hentges,et al.  The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. , 1999, Development.

[76]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[77]  S. Schreiber,et al.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Schwab,et al.  p70S6K Controls Selective mRNA Translation during Oocyte Maturation and Early Embryogenesis inXenopus laevis , 1999, Molecular and Cellular Biology.

[79]  T. Powers,et al.  Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. , 1999, Molecular biology of the cell.

[80]  C. Tokunaga,et al.  Alpha4 protein as a common regulator of type 2A‐related serine/threonine protein phosphatases 1 , 1999, FEBS letters.

[81]  M. Marahiel,et al.  Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts , 1999, Cellular and Molecular Life Sciences CMLS.

[82]  C. Cordon-Cardo,et al.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  G. Thomas,et al.  Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. , 1999, Current opinion in genetics & development.

[84]  F. Nielsen,et al.  A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development , 1999, Molecular and Cellular Biology.

[85]  J. Avruch,et al.  Regulation of Translational Effectors by Amino Acid and Mammalian Target of Rapamycin Signaling Pathways , 1999, The Journal of Biological Chemistry.

[86]  P. Houghton,et al.  Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation. , 1999, The Journal of biological chemistry.

[87]  Brian A. Hemmings,et al.  The Structure of the Protein Phosphatase 2A PR65/A Subunit Reveals the Conformation of Its 15 Tandemly Repeated HEAT Motifs , 1999, Cell.

[88]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[89]  Randall,et al.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12–rapamycin-associated protein , 1999 .

[90]  M. Schwab,et al.  p70 S6K Controls Selective mRNA Translation during Oocyte Maturation and Early Embryogenesis in Xenopus laevis , 1999 .

[91]  G. Blobel,et al.  Structure of the nuclear transport complex karyopherin-beta2-Ran x GppNHp. , 1999, Nature.

[92]  P. Tsichlis,et al.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. , 1999, Annual review of biochemistry.

[93]  I R Vetter,et al.  Structural view of the Ran-Importin beta interaction at 2.3 A resolution. , 1999, Cell.

[94]  Joe W. Gray,et al.  PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.

[95]  C. Sawyers,et al.  The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Lawrence,et al.  Attenuation of Mammalian Target of Rapamycin Activity by Increased cAMP in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[97]  A. Schmidt,et al.  The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease , 1998, The EMBO journal.

[98]  Stefano Fumagalli,et al.  Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.

[99]  R. Denton,et al.  Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111). , 1998, The Biochemical journal.

[100]  N. Rosen,et al.  Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[101]  M. Mcdaniel,et al.  Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. , 1998, The Journal of biological chemistry.

[102]  T. Mak,et al.  High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.

[103]  K. Yonezawa,et al.  Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. , 1998, Biochemical and biophysical research communications.

[104]  J. Sarkaria,et al.  Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. , 1998, Cancer research.

[105]  C. Proud,et al.  Amino acid availability regulates p70 S6 kinase and multiple translation factors. , 1998, The Biochemical journal.

[106]  M. West,et al.  Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway , 1998, Oncogene.

[107]  Carlos Cordon-Cardo,et al.  Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.

[108]  H. Sanjo,et al.  Ig receptor binding protein 1 (alpha4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. , 1998, Blood.

[109]  A. Gingras,et al.  Rapamycin and Wortmannin Enhance Replication of a Defective Encephalomyocarditis Virus , 1998, Journal of Virology.

[110]  S. Schreiber,et al.  Alpha 4 associates with protein phosphatases 2A, 4, and 6. , 1998, Biochemical and biophysical research communications.

[111]  R. Roth,et al.  Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[112]  J. Avruch,et al.  Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism* , 1998, The Journal of Biological Chemistry.

[113]  J. S. Britton,et al.  Environmental control of the cell cycle in Drosophila: nutrition activates mitotic and endoreplicative cells by distinct mechanisms. , 1998, Development.

[114]  D. Dixon,et al.  Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  M. Birnbaum,et al.  Construction and Characterization of a Conditionally Active Version of the Serine/Threonine Kinase Akt* , 1998, The Journal of Biological Chemistry.

[116]  G. Scheper,et al.  Regulation of translation initiation factors by signal transduction. , 1998, European journal of biochemistry.

[117]  A. Gingras,et al.  Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA , 1998, Oncogene.

[118]  C. Kahn,et al.  Bidirectional modulation of insulin action by amino acids. , 1998, The Journal of clinical investigation.

[119]  M. Mcdaniel,et al.  Insulin Mediates Glucose-stimulated Phosphorylation of PHAS-I by Pancreatic Beta Cells , 1998, The Journal of Biological Chemistry.

[120]  S. Snyder,et al.  RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[121]  A. Gingras,et al.  4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.

[122]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[123]  J. Downward,et al.  Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase , 1998, The EMBO journal.

[124]  M. Andjelkovic,et al.  Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.

[125]  L. Cantley,et al.  Phosphoinositide kinases. , 1998, Annual review of biochemistry.

[126]  T. Haystead,et al.  The Mammalian Target of Rapamycin Phosphorylates Sites Having a (Ser/Thr)-Pro Motif and Is Activated by Antibodies to a Region near Its COOH Terminus , 1997, The Journal of Biological Chemistry.

[127]  G. Thomas,et al.  TOR signalling and control of cell growth. , 1997, Current opinion in cell biology.

[128]  E. Garí,et al.  The Cln3 cyclin is down‐regulated by translational repression and degradation during the G1 arrest caused by nitrogen deprivation in budding yeast , 1997, The EMBO journal.

[129]  N. Sonenberg,et al.  Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A , 1997, Molecular and cellular biology.

[130]  K Dolinski,et al.  All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[131]  T. Fukuchi-Shimogori,et al.  Malignant transformation by overproduction of translation initiation factor eIF4G. , 1997, Cancer research.

[132]  M. Kasuga,et al.  Regulation of eIF-4E BP1 Phosphorylation by mTOR* , 1997, The Journal of Biological Chemistry.

[133]  M. Pfreundschuh,et al.  An amplified gene encodes the translation initiation factor elF-4gamma which induces an immune response in a patient with squamous cell lung carcinoma , 1997 .

[134]  A. Gingras,et al.  Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2. , 1997, Virology.

[135]  M. Polymenis,et al.  Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. , 1997, Genes & development.

[136]  Jun Wu,et al.  B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A , 1997 .

[137]  A. Gingras,et al.  The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k , 1997, Molecular and cellular biology.

[138]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[139]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[140]  J. Celis,et al.  Distinct repression of translation by wortmannin and rapamycin. , 1997, European journal of biochemistry.

[141]  L. Cantley,et al.  Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. , 1997, Science.

[142]  R. Pearson,et al.  Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.

[143]  J. Cheng,et al.  Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis , 1997, Oncogene.

[144]  J. Eberle,et al.  Translation initiation factor eIF‐4A1 mRNA is consistently overexpressed in human melanoma cells in vitro , 1997, International journal of cancer.

[145]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[146]  T. Haystead,et al.  Identification of Phosphorylation Sites in the Translational Regulator, PHAS-I, That Are Controlled by Insulin and Rapamycin in Rat Adipocytes* , 1997, The Journal of Biological Chemistry.

[147]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[148]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[149]  Marc Bickle,et al.  The Yeast Phosphatidylinositol Kinase Homolog TOR2 Activates RHO1 and RHO2 via the Exchange Factor ROM2 , 1997, Cell.

[150]  E. R. Seidel,et al.  Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC‐6 cells in culture , 1997, British journal of pharmacology.

[151]  M. Hentze eIF4G--A Multipurpose Ribosome Adapter? , 1997, Science.

[152]  M. Pfreundschuh,et al.  Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. , 1997, Human molecular genetics.

[153]  A. Gingras,et al.  The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. , 1996, Oncogene.

[154]  N. Sonenberg,et al.  Rapamycin stimulates viral protein synthesis and augments the shutoff of host protein synthesis upon picornavirus infection , 1996, Journal of virology.

[155]  C. Hellen,et al.  Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes , 1996, Molecular and cellular biology.

[156]  E. Hafen,et al.  The Drosophila phosphoinositide 3‐kinase Dp110 promotes cell growth. , 1996, The EMBO journal.

[157]  M. Hall,et al.  TOR2 is required for organization of the actin cytoskeleton in yeast. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[158]  J. Lawrence,et al.  Control of the Translational Regulators PHAS-I and PHAS-II by Insulin and cAMP in 3T3-L1 Adipocytes* , 1996, The Journal of Biological Chemistry.

[159]  L. Shantz,et al.  Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. , 1996, Cancer research.

[160]  G. Thomas,et al.  The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases , 1996, Molecular and cellular biology.

[161]  A. Gingras,et al.  Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. , 1996, Cancer research.

[162]  G. Thomas,et al.  The Drosophila p70s6k homolog exhibits conserved regulatory elements and rapamycin sensitivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[163]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[164]  N. Sonenberg,et al.  A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3 , 1996, Molecular and cellular biology.

[165]  S. Schreiber,et al.  A Signaling Pathway to Translational Control , 1996, Cell.

[166]  K. Arndt,et al.  Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. , 1996, Genes & development.

[167]  Stuart L. Schreiber,et al.  Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP , 1996, Science.

[168]  A. Gingras,et al.  4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[169]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[170]  A. Gingras,et al.  Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation. , 1996, The EMBO journal.

[171]  D. Templeton,et al.  Constitutive activation of S6 kinase by deletion of amino-terminal autoinhibitory and rapamycin sensitivity domains , 1996, Molecular and cellular biology.

[172]  R. Abraham,et al.  Immunopharmacology of rapamycin. , 1996, Annual review of immunology.

[173]  G. Thomas,et al.  14 Ribosomal Protein S6 Phosphorylation and Signal Transduction , 1996 .

[174]  O. Meyuhas,et al.  13 Translational Control of Ribosomal Protein mRNAs in Eukaryotes , 1996 .

[175]  M. Wickens,et al.  15 Translational Control of Developmental Decisions , 1996 .

[176]  I. Stansfield,et al.  An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast , 2012, Molecular biology of the cell.

[177]  J. Heitman,et al.  TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin (*) , 1995, The Journal of Biological Chemistry.

[178]  S. Schreiber,et al.  Control of p70 S6 kinase by kinase activity of FRAP in vivo , 1995, Nature.

[179]  Peer Bork,et al.  HEAT repeats in the Huntington's disease protein , 1995, Nature Genetics.

[180]  F. Nielsen,et al.  Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway , 1995, Nature.

[181]  R. Rhoads,et al.  Mapping of Functional Domains in Eukaryotic Protein Synthesis Initiation Factor 4G (eIF4G) with Picornaviral Proteases , 1995, The Journal of Biological Chemistry.

[182]  M. Connelly,et al.  DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product , 1995, Cell.

[183]  J. Cheng,et al.  Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas , 1995, International journal of cancer.

[184]  P. Blackshear,et al.  Control of PHAS-I by Insulin in 3T3-L1 Adipocytes , 1995, The Journal of Biological Chemistry.

[185]  N. Sonenberg,et al.  The Saccharomyces cerevisiae translation initiation factor Tif3 and its mammalian homologue, eIF‐4B, have RNA annealing activity. , 1995, The EMBO journal.

[186]  O. Hazeki,et al.  Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. , 1995, Trends in biochemical sciences.

[187]  Stuart L. Schreiber,et al.  TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin , 1995, Cell.

[188]  N. Sonenberg,et al.  Translational control of gene expression , 2000 .

[189]  K. Maeda,et al.  Molecular cloning of a cDNA clone encoding a phosphoprotein component related to the Ig receptor-mediated signal transduction. , 1995, Journal of immunology.

[190]  R. Abraham,et al.  Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[191]  V. Berlin,et al.  RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[192]  A. Nairn,et al.  Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[193]  N. Sonenberg,et al.  PHAS-I as a link between mitogen-activated protein kinase and translation initiation. , 1994, Science.

[194]  A. Gingras,et al.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.

[195]  K. Nakanishi,et al.  A putative sirolimus (rapamycin) effector protein. , 1994, Biochemical and biophysical research communications.

[196]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[197]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[198]  J. Hershey,et al.  Two structural domains of initiation factor eIF-4B are involved in binding to RNA. , 1994, The Journal of biological chemistry.

[199]  G. Thomas,et al.  Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[200]  J. Dodge,et al.  Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. , 1994, Cancer research.

[201]  M. Mclaughlin,et al.  Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. , 1994, Gene.

[202]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[203]  J. Kunz,et al.  TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. , 1994, Molecular biology of the cell.

[204]  R. Panniers Translational control during heat shock. , 1994, Biochimie.

[205]  B. Wittmer,et al.  A Saccharomyces cerevisiae homologue of mammalian translation initiation factor 4B contributes to RNA helicase activity. , 1993, The EMBO journal.

[206]  P. Linder,et al.  A new yeast translation initiation factor suppresses a mutation in the eIF‐4A RNA helicase. , 1993, The EMBO journal.

[207]  M. Mclaughlin,et al.  Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity , 1993, Molecular and cellular biology.

[208]  J. Kunz,et al.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.

[209]  N. Sonenberg,et al.  Remarks on the mechanism of ribosome binding to eukaryotic mRNAs. , 1993, Gene expression.

[210]  N. Sonenberg,et al.  mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.

[211]  J. Cheng,et al.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[212]  M. Kozak,et al.  An analysis of vertebrate mRNA sequences: intimations of translational control , 1991, The Journal of cell biology.

[213]  J. Testa,et al.  A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. , 1991, Science.

[214]  J. Heitman,et al.  Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.

[215]  D. Bergsma,et al.  Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. , 1991, Molecular and cellular biology.

[216]  J. Heitman,et al.  FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[217]  P. Blackshear,et al.  Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E. , 1991, The Journal of biological chemistry.

[218]  K. O. Elliston,et al.  FKBl encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[219]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[220]  N. Sigal,et al.  The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. , 1990, The Journal of biological chemistry.

[221]  S. Morley,et al.  Differential stimulation of phosphorylation of initiation factors eIF-4F, eIF-4B, eIF-3, and ribosomal protein S6 by insulin and phorbol esters. , 1990, The Journal of biological chemistry.

[222]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.

[223]  N. Sonenberg,et al.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F , 1990, Molecular and cellular biology.

[224]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[225]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[226]  S. Morley,et al.  Phorbol esters stimulate phosphorylation of eukaryotic initiation factors 3, 4B, and 4F. , 1989, The Journal of biological chemistry.

[227]  M. Kozak The scanning model for translation: an update , 1989, The Journal of cell biology.

[228]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[229]  J. Hershey,et al.  Regulation of initiation factors during translational repression caused by serum depletion. Covalent modification. , 1985, The Journal of biological chemistry.

[230]  L. Cantley,et al.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[231]  R. Benne,et al.  The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. , 1978, The Journal of biological chemistry.

[232]  R. Traut,et al.  Phosphorylation of eukaryotic protein synthesis initiation factors. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[233]  B. Erni,et al.  Initiation of mammalian protein synthesis. I. Purification and characterization of seven initiation factors. , 1977, Journal of molecular biology.

[234]  R. Benne,et al.  Purification and characterization of initiation factors IF-E4 and IF-E6 from rabbit reticulocytes. , 1977, Journal of Biological Chemistry.

[235]  H. Lodish Translational control of protein synthesis. , 1976, Annual review of biochemistry.

[236]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. , 1975, The Journal of antibiotics.

[237]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. , 1975, The Journal of antibiotics.